TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
MBX

MBX Biosciences, Inc.

Healthcare · Biotechnology

55.40$ -4.3% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet MBX
Line item 2022 2023 2024 2025
– +86.7% +219.0% +43.4%
– +88.8% +220.2% +42.7%
– +26.1% +61.7% +52.6%
– +90.0% +224.9% +42.6%
– +46.5% +227.9% +210.9%
– +78.6% -92.9% +43.5%
– +14.4% +181.5% +40.2%
– +11.7% +11.8% +0.6%
– +42.5% +283.5% -44.2%
– – – +43.4%
– – – –
– +0.0% +4.8% +9.3%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?